![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on Investigating a Switch Maintenance Concept With 5-FU + Bev After FOLFIRI + Cetuximab Induction Treatment vs. Continued Treatment With FOLFIRI + Cetuximab: Report of a Secondary Endpoint of the Phase-III FIRE-4 Study
By
ASCO 2022 Conference Coverage
FEATURING
Sebastian Stintzing
By
ASCO 2022 Conference Coverage
FEATURING
Sebastian Stintzing
195 views
June 14, 2022
Login to view comments.
Click here to Login
GI